View of EVALUATING THE OUTCOMES OF NEOADJUVANT CHEMOTHERAPY WITH PACLITAXEL-CARBOPLATIN IN THREE CYCLES FOR STAGE III-IV OVARIAN CARCINOMA AT CAN THO ONCOLOGY HOSPITAL IN 2024-2025

Return to Article Details EVALUATING THE OUTCOMES OF NEOADJUVANT CHEMOTHERAPY WITH PACLITAXEL-CARBOPLATIN IN THREE CYCLES FOR STAGE III-IV OVARIAN CARCINOMA AT CAN THO ONCOLOGY HOSPITAL IN 2024-2025 Download Download PDF